跳至主要内容
临床试验/JPRN-UMIN000006663
JPRN-UMIN000006663尚未招募未知

Efficacy of ramosetron hydrochloride in male patients with diarrhea-predominant irritable bowel syndrome - Efficacy of ramosetron hydrochloride in male patients with diarrhea-predominant irritable bowel syndrome

Shimane University Faculty of Medicine, Department of Gastroenterology and Hepatology0 个研究点目标入组 200 人开始时间: 2011年11月10日最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
Male

入选标准

  • 未提供

排除标准

  • 1) Patients who have bowel move disturbance by organic lesion such as IBD (UC and Crohn disease etc.) and cancer. 2) Patients suspected of obstruction in stomach and intestines, and with a history of total gastric resection or bowel resection but not appendectomy 3) Patients with serious complications (liver, kidney, heart, lung, circulatory, or metabolic disorder) 4) Patients with a history of drug allergy 5) Others, including patients who are unfit for the study as determined by the attending doctor 6) Patients who are taking polycarbophil calcium.

研究者

发起方
Shimane University Faculty of Medicine, Department of Gastroenterology and Hepatology

相似试验